By applying meta-analysis, a powerful tool which can combine the results of different randomized controlled studies, nine reports with 264 cases and 227 healthy controls were analyzed to investigate whether elevated serum TGF-β1 is a risk factor for the development of diabetic nephropathy. Here, TGFB1 is linked to diabetic kidney disease.